Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2021 Sep 17;398(10309):1404–1405. doi: 10.1016/S0140-6736(21)02013-4

An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 – Authors' reply

Gerald T Keusch a, Sai Kit Lam b, John S Mackenzie c, Linda Saif d, Michael Turner e
PMCID: PMC8448489  PMID: 34543607

We write on behalf of our coauthors1 to agree with Jacques van Helden and colleagues that scientists “need to evaluate all hypotheses on a rational basis, and to weigh their likelihood based on facts and evidence, devoid of speculation concerning possible political impacts”. Scientific knowledge is essential to effectively guide future efforts to reduce the chance of another pandemic,1, 2 including by mitigating or blocking all relevant pathways for a pathogen to host-shift from natural hosts to humans. Endless arguments back and forth about the emergence of SARS-CoV-2, pitting evolution and spillover in nature against a laboratory leak do little to advance our critical knowledge base. We need more scientific evidence that unravels the likely pathway for the virus because real evidence that confirms or refutes hypotheses is far more important than the hypotheses and conjectures themselves. Expert reviews and new data continue to emerge tracing the evolutionary pathway of SARS-CoV-2 in nature over decades, serving to place some controversial genomic characteristics within a broader evolutionary context.3, 4, 5 However, while we need more evidence, the world will remain mired in dispute without full engagement of China, including open access to primary data, documents, and relevant stored material to enable a thorough, transparent, and objective search for all relevant evidence. As we have already seen6 this engagement is impossible in an environment of implicit or explicit blame placed on the Wuhan Institute of Virology and its scientists. We stand by our statement that “recrimination has not, and will not, encourage international cooperation and collaboration”.1

Acknowledgments

JSM is a member of the WHO International Health Regulations Emergency Committee for COVID-19, a member of the One Health High Level Expert Panel that advises the Food and Agriculture Organization of the UN, the World Organisation for Animal Health, the United Nations Environment Programme, and WHO, and a past member of the scientific advisory committee for the Center for Emerging Infectious Diseases of the Wuhan Institute of Virology (2008–11). JSM has past or ongoing academic and scientific collaborations on coronavirus biology with colleagues in China and several other countries. GTK, SKL, and LS are members of the Lancet Task Force on the Origins and Early Spread of COVID-19 & One Health Solutions to Future Pandemic Threats. MT declares no competing interests.

References


Articles from Lancet (London, England) are provided here courtesy of Elsevier

RESOURCES